(Q46823552)

English

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

scientific article published on 20 October 2014

Statements

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit